SEI Investments’s Precigen PGEN Stock Holding History

SEI Investments’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$723K	Buy	126,882 +115,083	+975%	+$497K	﹤0.01%	2472
2026 Q1	$45.7K	Sell	11,799 -36,272	-75%	-$149K	﹤0.01%	3178
2025 Q4	$201K	Sell	48,071 -24,960	-34%	-$96.6K	﹤0.01%	2903
2025 Q3	$240K	Buy	+73,031	New	+$206K	﹤0.01%	2552
2023 Q3	–	Sell	-1,045,167	Closed	-$1.2M	–	2677
2023 Q2	$1.2M	Hold	1,045,167	–	–	﹤0.01%	1826
2023 Q1	$1.11M	Buy	1,045,167 +227,852	+28%	+$329K	﹤0.01%	1835
2022 Q4	$1.24M	Sell	817,315 -16,000	-2%	-$27.5K	﹤0.01%	1681
2022 Q3	$1.77M	Buy	833,315 +16,000	+2%	+$33.7K	﹤0.01%	1599
2022 Q2	$1.09M	Hold	817,315	–	–	﹤0.01%	1789
2022 Q1	$1.73M	Buy	817,315 +45,802	+6%	+$112K	﹤0.01%	1597
2021 Q4	$2.86M	Buy	771,513 +382,625	+98%	+$1.65M	0.01%	1420
2021 Q3	$1.94M	Hold	388,888	–	–	﹤0.01%	1524
2021 Q2	$2.54M	Hold	388,888	–	–	0.01%	1410
2021 Q1	$2.68M	Buy	+388,888	New	+$3.29M	0.01%	1331
2019 Q1	–	Sell	-208,768	Closed	-$1.45M	–	2958
2018 Q4	$3.6M	Hold	208,768	–	–	0.01%	1058
2018 Q3	$3.6M	Sell	208,768 -9,644	-4%	-$143K	0.01%	1031
2018 Q2	$3.04M	Sell	218,412 -32,654	-13%	-$552K	0.01%	1153
2018 Q1	$3.85M	Buy	251,066 +86,656	+53%	+$1.24M	0.01%	952
2017 Q4	$1.89M	Buy	164,410 +42,602	+35%	+$634K	0.01%	1307
2017 Q3	$2.32M	Sell	121,808 -412	-0.3%	-$8.48K	0.01%	1167
2017 Q2	$2.94M	Buy	122,220 +1,895	+2%	+$41.6K	0.01%	1056
2017 Q1	$2.38M	Buy	120,325 +7,811	+7%	+$174K	0.01%	1089
2016 Q4	$2.71M	Sell	112,514 -5,175	-4%	-$144K	0.01%	1035
2016 Q3	$3.27M	Buy	117,689 +3,303	+3%	+$87.3K	0.02%	883
2016 Q2	$2.79M	Buy	114,386 +8,627	+8%	+$245K	0.02%	879
2016 Q1	$3.55M	Buy	105,759 +13,731	+15%	+$432K	0.02%	738
2015 Q4	$2.75M	Buy	92,028 +30,030	+48%	+$1.01M	0.02%	878
2015 Q3	$1.95M	Buy	61,998 +13,667	+28%	+$667K	0.02%	812
2015 Q2	$2.34M	Buy	48,331 +1,755	+4%	+$74K	0.02%	702
2015 Q1	$2.02M	Buy	46,576 +8,360	+22%	+$300K	0.02%	730
2014 Q4	$1.01M	Buy	+38,216	New	+$838K	0.01%	942

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SEI Investments's PGEN Position: Q2 2026 in Review

SEI Investments increased its Precigen (PGEN) stake by 975% in Q2 2026, buying an estimated $497K and bringing the position to 126,882 shares worth $723K. The position accounts for ﹤0.01% of the portfolio, ranked #2472.

SEI Investments first reported a position in PGEN in Q4 2014 and has held it in 31 quarters since. The position peaked at $3.85M in Q1 2018. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

SEI Investments held 126,882 shares of Precigen worth $723K as of Q2 2026.
SEI Investments bought 115,083 Precigen shares in Q2 2026, an estimated $497K.
Precigen made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2472 holding.
SEI Investments first reported a position in Precigen in Q4 2014 and has held it in 31 quarters since.
SEI Investments's Precigen position peaked at $3.85M in Q1 2018.
211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.